Phase 2 Southwest Oncology Group-directed intergroup trial (S0505) of sorafenib in advanced soft tissue sarcomas

  • Margaret Von Mehren
  • , Cathryn Rankin
  • , John R. Goldblum
  • , George D. Demetri
  • , Vivien Bramwell
  • , Christopher W. Ryan
  • , Ernest Borden

Research output: Contribution to journal › Article › peer-review

101 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 2 Southwest Oncology Group-directed intergroup trial (S0505) of sorafenib in advanced soft tissue sarcomas'. Together they form a unique fingerprint.

Medicine and Dentistry